Incorrect username and/or password, please try again or click to reset.

Company led medicines recall: Mawdsley-Brooks & Company Limited, Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection, CLMR(23)A/01

2023-01-12 14:05:17 (1 year(s) ago)


Specific batches of the product are recalled as a precautionary measure due to validation tests demonstrating the leaching of filter additives that are above the acceptable limit.

Read full MHRA article

Respond to this alert